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ReviewInsights into Programmed Cell Death
through Structural Biology
(Strauss et al., 1999). Inappropriate apoptosis also con-
tributes to several neurological disorders. In Alzhei-
mer’s, Parkinson’s, and Huntington’s disease, specific
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neurons prematurely commit suicide, which can lead to
irreversible memory loss, uncontrolled muscular move-
ments, and depression.Programmed cell death plays a critical role in controlling
In the last few years, much has been learned aboutthe number of cells in development and throughout an
the signal transduction pathways of programmed cellorganism’s life by the removal of cells at the appropriate
death, providing us with insight into how programmedtime. It is an important biological process for the elimina-
cell death works and how dysregulation of apoptosistion of unwanted cells such as those with potentially
contributes to disease. The overall process of pro-harmful genomic mutations, autoreactive lymphocytes,
grammed cell death occurs in several stages. In the firstor virally infected cells. Alterations of this normal pro-
step, the apoptotic pathway is triggered, which can becess can result in the disruption of the delicate balance
accomplished by a wide variety of stimuli, including DNAbetween cell proliferation and cell death and can lead
damage, growth factor withdrawal, toxins, and radiation.to a variety of diseases (Thompson, 1995). For example,
Once activated, the signal is transduced by a series ofin many forms of cancer, key proapoptotic proteins are
protein–protein interactions that involve a conserved setmutated or antiapoptotic proteins are upregulated, lead-
of signaling modules. In the next stage, cell death ising to the accumulation of cells and the inability to
executed by the activation of specific proteases calledrespond to harmful mutations, DNA damage, or chemo-
caspases that cleave multiple substrates, leading totherapeutic agents. Since effective chemotherapy de-
changes characteristic of apoptotic cells such as DNApends on the induction of programmed cell death, can-
fragmentation, chromatin condensation, cell shrinkage,cers with defects in the cell death signaling pathways
and membrane blebbing.are particularly difficult to treat. Programmed cell death
The signaling pathways of programmed cell death canis also important for eliminating autoreactive T cells after
be divided into two components, involving either thean immune response. When this normal process is dis-
mitochondria or death receptors (Figure 1) (Budihardjorupted through mutations of the proteins that trigger
et al., 1999). In the death receptor pathway, receptorsapoptosis (e.g., Fas ligand or the Fas receptor), an auto-
such as TNFR1, Fas, DR-3, DR-4, or DR-5 interact withimmune lymphoproliferative syndrome (ALPS) can result,
their cognate ligands. This binding event allows thewith complications such as hypersplenism, autoimmune
hemolytic anemia, thrombocytopenia, and neutropenia recruitment of downstream signaling partners, which
Figure 1. Signaling Pathways of Programmed Cell Death
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Figure 2. Three-Dimensional Structures of
Death Receptor/Ligand Complexes
(A) The structure of the TNFb trimer (orange,
yellow, and green) complexed to three TNF
receptor molecules (magenta, blue, and red).
The side chains of the cysteines that form
disulfides are shown in gray (Banner et al.,
1993).
(B) The X-ray structure of TRAIL (orange, yel-
low, and green) complexed to DR5 (magenta,
blue, and red) (Hymowitz et al. 1999).
ultimately results in the activation of caspases and sub- These structures have helped us understand apoptosis
at the molecular level by defining the interactions thatsequent cell death. For example, in Fas-mediated apo-
ptosis, the Fas ligand interacts with the Fas receptor, stabilize complex formation, guiding site-directed muta-
genesis experiments, elucidating enzyme mechanisms,which leads to an interaction between the death domain
of the cytoplasmic region of the Fas receptor and the and characterizing protein function. In this review, a
compendium of recently determined three-dimensionaldeath domain of the adaptor protein, FADD. FADD re-
cruits and activates procaspase-8 through interactions structures of proteins involved in the cell death signal-
ing pathways is described along with the informationbetween the death effector domains of these two pro-
teins. Once activated, caspase-8 activates downstream learned from these structures relevant to the chemistry
and biology of apoptosis.caspases such as caspase-3 (for a review, see Nagata,
1997).
In the mitochondrial pathway, cytochrome c is re- Death Receptors—Initiators of Apoptosis
Tumor necrosis factor (TNF) is the prototypic memberleased from the intermembrane space of mitochondria
upon activation via a death signal. Although the details of a family of cytokines that interact with a large number
of receptors. Activation of these receptors by ligandof this process at the molecular level are unknown, cyto-
chrome c and ATP or dATP bind to the protein Apaf-1 binding leads to many diverse activities such as cell
proliferation, differentiation, and apoptosis. The subsetto form a multimeric complex that recruits and activates
procaspase-9. This is followed by the activation of cas- of receptors responsible for eliciting programmed cell
death all contain an intracellular death domain (Tartagliapase-3 and -7 (Budihardjo et al., 1999).
As one might imagine, apoptosis is highly regulated. et al., 1993).
TNFa and TNFb were found to crystallize as trimersOne class of regulators is the Bcl-2 family of proteins.
Antiapoptotic family members such as Bcl-2 and Bcl- (Jones et al., 1989; Eck and Sprang, 1989; Eck et al.,
1992). The structures of these proteins are similar andxL inhibit the release of cytochrome c whereas the pro-
apoptotic proteins Bax and tBID promote cytochrome adopt the shape of a truncated pyramid. Each monomer
consists of a b sandwich with a jellyroll topology. Thec release from the mitochrondria. Pro- and antiapoptotic
members of the Bcl-2 family interact with one another structure of the complex between TNFb and the soluble
extracellular region of the TNF receptor (TNF-R1) pro-and modulate each others’ activities (Yin et al., 1994).
Additional regulators of this pathway are the IAPs. One vided the first view of the receptor and the interactions
that stabilize complex formation between these twoof their major functions is to bind to and inhibit the
effectors of apoptosis—the caspase family of enzymes families of proteins (Figure 2A) (Banner et al., 1993). The
extracellular portion of TNF-R1 consists of four pseudo(Deveraux and Reed, 1999).
The three-dimensional structures for a number of pro- repeats, called cysteine-rich domains (CRDs), which
each contain three disulfides formed from six conservedteins and protein domains involved in the signaling path-
ways of programmed cell death have been determined. cysteines. Three elongated receptor molecules bind to
Figure 3. The Structures of Three Modules
Involved in the Signal Transduction of Pro-
grammed Cell Death
Ribbons (Carson, 1987) depiction of the: (A)
Fas death domain (Huang et al., 1996), (B)
FADD death effector domain (Eberstadt et al.,
1998), and (C) RAIDD CARD (Chou et al., 1998).
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one TNF trimer at the interfaces formed between the TNF The overall fold of other death domains were found
monomers (Figure 2A). There are two principal regions of to be similar to the Fas death domain with only minor
contact in the complex that involve loops from the sec- differences in the length and orientation for some of
ond (50s loop) and third (90s loop) cysteine-rich domains the a helices (Liepinsh et al., 1997; Jeong et al., 1999).
of the TNF receptor and two distinct regions of TNFb. However, the manner in which death domains or mod-
On the basis of the structure of the TNFb/TNF-R1 com- ules with similiar folds interact with one another was
plex, a model was proposed for TNF-mediated signaling found to be different. This was recently illustrated in the
in which the TNF trimer induces trimerization of the re- X-ray structure of a complex between the interacting
ceptor, which causes the cytoplasmic regions of the domains of the serine/threonine kinase Pelle and the
receptor to form a cluster. The cytoplasmic region of adaptor protein Tube that recruits Pelle to the plasma
TNF-R1 and other death receptors contain death do- membrane during Drosophila embryogenesis (Xiao et
mains that oligomerize and recruit death domain– al., 1999). Although not involved in apoptosis, the inter-
containing adaptor proteins, leading to the downstream acting domains of Pelle and Tube adopt the same overall
signaling of programmed cell death (Figure 1). fold as death domains but do not appear to interact in
Recently, the crystal structure was determined of an- the same manner as the Fas and FADD death domains.
other death receptor, DR5, complexed to the ligand Unlike the second and third a helices, which have been
TRAIL (also called Apo2L) (Figure 2B) (Hymowitz et al., implicated in the Fas death domain for binding to FADD,
1999; Mongkolsapaya et al., 1999). The overall structure residues in the fourth and fifth a helices in Pelle and the
of the TRAIL/DR5 complex is similar to TNFb/TNF-R1. sixth a helix in Tube were found to play a critical role
However, there are some important differences that de- in complex formation for these proteins such that the
fine the binding specificities observed within these fami- binding interface involves a unique surface that is not
lies of ligands and receptors. Unlike the TNF receptor even present in other death domains.
that contains four extracellular cysteine-rich domains, The death effector domain of FADD (Figure 3B) adopts
DR5 contains only two CRDs, which correspond to do- a fold that is similar to that of the death domains (Eber-
mains 2 and 3 of TNF-R1. CRD2 of DR5 interacts with stadt et al., 1998). However, mutations in the Fas death
TRAIL in a similar fashion as observed for the corre- domain that inhibit the binding of Fas to FADD have no
sponding residues in the TNF-b/TNF-R1 complex (Fig- effect when introduced in the FADD DED. In contrast to
ure 2). However, CRD3 of DR5, when bound to TRAIL, the charged surface of the Fas DD, the FADD DED has
adopts a different relative orientation compared to two hydrophobic patches. One of these patches con-
CRD3 of TNF-R1 in the TNFb/TNF-R1 complex and tains a conserved set of hydrophobic residues that is
forms a different set of interactions. The binding speci- important for its apoptotic activity and binding to the
ficity observed in the TNF receptor superfamily could be DEDs of procaspase-8.
important for developing selective therapeutic agents. The three-dimensional structures of RAIDD CARD
Unlike TNF and Fas ligand, which are highly toxic, TRAIL (Figure 3C) (Chou et al., 1998) and Apaf-1 CARD (Day
selectively triggers apoptosis in tumor cells versus nor- et al., 1999; Qin et al., 1999; Vaughn et al., 1999; Zhou
mal tissues and, when given to mice with human tumors, et al., 1999) also adopt the same fold as the death do-
causes tumors to shrink without any apparent toxicity main and the death effector domain. Thus, all three sig-
(Walczak et al., 1999). naling modules (DD, DED, and CARD) that participate
in homophilic interactions to transduce the cell death
Signaling Modules that Transduce the Death Signal signal adopt very similar structures. This is consistent
A common theme in the signaling pathways of pro- with the presence of a conserved set of hydrophobic
grammed cell death is the association of proteins that amino acids in all of these domains that compose the
contain similar domains. Four protein modules have hydrophobic core of the proteins (Hofmann et al., 1997).
been identified that participate in cell death signaling
The differences between the domains are the surface
through protein–protein interactions. These include the
residues that stabilize complex formation. In the Apaf-1
death domain (DD), death effector domain (DED), cas-
CARD/procaspase-9 CARD complex (Qin et al., 1999),pase recruitment domain (CARD), and the N-terminal
the positively charged surface formed by the basic resi-domains of DFF45, DFF40, and cell death-inducing
dues Arg13, Arg52, and Arg56 of procaspase-9 CARDDFF45-like effector (CIDE) proteins.
interacts with the negatively charged face of Apaf-1The death domain is found in the intracellular portion
CARD, which is composed of Asp27 and Glu40 (Fig-of death receptors whereas the death effector and cas-
ure 4).pase recruitment domains are found in adaptor proteins
Another domain that participates in homophilic inter-such as FADD and procaspases. The three-dimensional
actions in the programmed cell death cascade is foundstructure of the Fas death domain was the first structure
in the N terminus of DFF45, DFF40, and CIDE proteins.reported for one of these signaling modules (Huang et
DFF45 (also called ICAD) forms a complex with DFF40al., 1996). The structure contains six antiparallel, amphi-
(also called CAD) through interactions involving theirpathic a helices with an unusual topology (Figure 3A).
N-terminal domains and inhibits the DNA nuclease activ-The surface of the Fas death domain mainly consists of
ity of DFF40, which is localized in the C-terminal portioncharged residues, suggesting that charge–charge inter-
of the protein (Liu et al., 1997; Enari et al., 1998). Cas-actions mediate complex formation between the death
pase-3 cleaves DFF45, which causes the release ofdomains. This was supported by site-directed mutagen-
DFF40 from the DFF45/DFF40 complex and triggersesis in which the mutation of charged residues in the
DNA fragmentation and nuclear condensation. Thesecond and third a helices of the Fas DD reduced bind-
ing to FADD. three-dimensional structure of the N-terminal domain of
Cell
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Figure 4. X-Ray Structure of a CARD/CARD Complex
(A) The positively charged Arg13, Arg52, and Arg56 of procas- Figure 5. X-Ray Structure of a Caspase-3/Inhibitor Complex
pase-9 CARD (left) interact with the negatively charged residues
After processing, activated caspases form a tetramer in which the(Asp27 and Glu40) of Apaf-1 CARD (right) (Qin et al., 1999).
C-terminal ends of the large subunits (blue and yellow) are closer(B) GRASP (Nicholls et al., 1991) depiction of the electrostatic sur-
to the N-terminal ends of the small subunits (orange and magenta)face of procaspase-9 CARD (left) and Apaf-1 CARD (right).
in the adjacent heterodimer. The inhibitor (color coded by atom
type) interacts in a pocket formed between the two subunits on
each side of caspase-3 (Mittl et al., 1997).
the proapoptotic CIDE-B protein was determined (Lu-
govskoy et al., 1999). The structure consists of a twisted,
the P2–P4 positions differs among caspase family mem-five-stranded b sheet and two a helices arranged in an
bers and defines their substrate specificity (Thornberrya/b roll fold that is very different from the structure of the
et al., 1997). The initiator caspases such as caspase-8DD, DED, and CARDs that also participate in homophilic
and caspase-9 prefer (V,L)EXD-containing substratesinteractions in cell death signaling. On the basis of the
like those found in the cleavage sites used to processstructure, a model was proposed for the homophilic
caspase zymogens into active enzymes. In contrast, theinteractions involving the N-terminal CIDE domains in-
effector caspases cleave DEXD-containing substratesvolving complementary neutralization of their charged
such as those found in structural proteins that aresurfaces.
cleaved during apoptosis, resulting in the typical mor-
phological changes in the cell.
X-ray crystal structures of caspase-1, (Walker et al.,Executioners of Programmed Cell Death
The family of cysteine proteases called caspases play 1994; Wilson et al., 1994) caspase-3 (Rotonda et al., 1996;
Mittl et al., 1997), and caspase-8 (Blanchard et al., 1999;a central role in the execution of programmed cell death
by cleaving a wide variety of substrates (e.g., DFF45), Watt et al.,1999) covalently attached to irreversible pep-
tidic inhibitors have been determined. The overall archi-leading to the characteristic morphological changes as-
sociated with apoptosis. Caspases can be divided into tecture of these three caspases is similar and consists
of two heterodimers composed of a large and smalltwo types—those with large prodomains that function
upstream as initiators of the death cascade and those subunit that form a tetramer (Figure 5). The mature
enzymes are derived by proteolytically removing thewith a small prodomain that act downstream as ef-
fectors. As described above, the prodomains of the initi- N-terminal prodomains and cleaving the proenzymes
between the large and small subunits. In the X-ray struc-ator caspases contain either a DED or CARD. These
domains interact with other signaling proteins that con- tures of the processed enzymes, the C terminus of the
large subunit (Figure 5, blue) is far away from the Ntain these modules through homophilic interactions.
This binding event triggers the activation of the initiator terminus of the small subunit (magenta) in the hetero-
dimer, but is very close to the N terminus of the smallcaspases by bringing together the proenzymes, allowing
autolytic processing in trans as a result of their induced subunit (orange) in the adjacent protein. This observa-
tion suggests that the large subunit in the heterodimerproximity (Salvesen and Dixit, 1999).
All caspases have a distinct substrate specificity that may have been linked before processing to the small
subunit in the adjacent heterodimer. Alternatively, arequires cleavage after an aspartic acid at the P1 position
N-terminal to the cleavage site. The preference of amino large conformational change may occur upon auto-
processing.acids further to the N terminus of peptide substrates at
Review
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Figure 7. Proposed Enzymatic Mechanism of the Caspases
histidine is critical for protonating the a-amino group of
the scissile bond that favors the release of the leaving
group and increases the nucleophilicity of a water mole-
Figure 6. Blow-Up Depicting Caspase-3/Inhibitor Interactions cule to aid in the cleavage of the thiol ester (Figures 7C
and 7D).
In addition to providing information on the possible
Regulators of Apoptosis
mechanisms of activation, the X-ray structures of cas-
Several proteins have been discovered that regulate
pase/inhibitor complexes revealed the structural basis
apoptosis. In cancer, the levels of these proteins are
for the observed substrate specificity. The requirement
often altered to allow cancer cells to stay alive even
for an aspartic acid at the P1 position in all substrates though the cell death pathways have been triggered.
and substrate-based inhibitors could be explained by
Moreover, viruses have engineered mimics of these pro-
the favorable interaction of this aspartic acid with two teins that allow the host cell to stay alive long enough
highly conserved arginines and a glutamine. In cas- for the virus to replicate. Thus, these proteins serve as
pase-3, these residues correspond to Arg64, Arg207, possible targets for the regulation of apoptosis.
and Gln161 (Figure 6). The differences in substrate spec- IAPs
ificity within the caspase family can also be explained The inhibitor of apoptosis (IAP) family of proteins repre-
from the X-ray structures. In caspase-1, the P4 binding sent an important class of regulators of programmed cell
site (S4 subsite) is a large hydrophobic pocket that can death. They were initially discovered in baculoviruses
accommodate several residues. In contrast, caspase-3 where they were found to inhibit apoptosis in host cells
has a relatively narrow pocket that forms hydrogen during viral infection (Crook et al., 1993). Subsequently,
bonds with the aspartic acid preferred at the P4 position IAPs have been found in other viruses, yeast, flies,
(Figure 6). Caspase-8 differs from the other caspases worms, and mammals (Uren et al., 1998).
in both the S3 and S4 specificity pockets, resulting in the All IAPs contain one to three baculovirus IAP repeat
preference for glutamic acid at P3 and for small hy- (BIR) domains which are composed of about 70 amino
drophobic amino acids at P4. acids and have a characteristic signature sequence
Based on the location of the amino acids in the active (CX2CX16HX6C). Some of the IAPs also contain a C-termi-
site observed in the X-ray structures, an enzymatic nal ring finger. Several functions have been attributed
mechanism was proposed for the caspases (Figure 7). to the IAPs. In Drosophila, IAPs have been shown to
Like other cysteine proteases, the sulfur of the active interact with the proapoptotic proteins REAPER, HID,
site cysteine acts as a nucleophile to form a tetrahedral and GRIM (Vucic et al., 1998; Goyal et al., 2000). The
intermediate (Figure 7B). A nearby histidine increases mammalian IAPs, cIAP-1 (MIHB) and cIAP-2 (MIHC),
the nucleophilicity of the sulfur by acting as a base and bind to TNF-receptor associated factors (TRAFS) 1 and
abstracting a proton (Figure 7A). Some investigators 2, while survivin (Ambrosini et al., 1997), has been impli-
have postulated that a Cys/His dyad is involved in the cated in the cell cycle (Li et al., 1998a). Some IAPs
enzymatic mechanism whereas others have proposed have also been shown to potently inhibit caspases. For
a catalytic triad. The high resolution (1.2 A˚) structure of example, human XIAP inhibits caspases-3 and -7 with
a caspase-8/inhibitor complex supports a catalytic triad Ki’s of 0.2–0.7 nM (Deveraux et al., 1997) and also inhibits
in which a clear interaction is observed between the caspase-9 (Deveraux et al., 1999). The portion of XIAP
backbone carbonyl of Arg258 to His317 that enhances responsible for inhibiting caspase-3 was found to con-
the basicity of the histidine. Arg258 in caspase-8 is tain the BIR2 domain (Takahashi et al., 1998) whereas
equivalent to Pro177 in caspase-1 and Thr62 in cas- the BIR3 domain of XIAP was shown to inhibit caspase-9
pase-3. Thus, it appears that the identity of the third (Deveraux et al., 1999; Sun et al., 2000).
residue of the catalytic triad is irrelevant, which is consis- The NMR structure of a BIR2-containing portion of
tent with the observed interaction involving a backbone XIAP that inhibits caspase-3 has been recently deter-
carbonyl. In addition to the importance of the histidine mined (Sun et al., 1999). The structure of the BIR2 do-
main of XIAP consists of a three-stranded antiparallelas a general base in the reaction mechanism, the same
Cell
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Figure 9. Structural Comparison of Bcl-xL and the Pore Forming
Domain of Diphtheria Toxin
Both Bcl-xL (A) and diphtheria toxin (B) contain two central hy-
drophobic helices (red) surrounded by amphipathic a helices
(Muchmore et al., 1996).
Figure 8. NMR Structure of a region of XIAP containing the BIR2
Domain a possible target for the development of drugs that se-
The zinc (magenta) chelates to three cysteines and one histidine lectively eliminate cancer cells. The X-ray crystal struc-
(Sun et al., 1999). tures of survivin reveal basic, acidic, and hydrophobic
patches on the surface of the protein that could bind to
small molecules capable of inhibiting survivin’s function.b sheet and four a helices and resembles a classical
Bcl-2 Family of Proteinszinc finger (Figure 8). The three conserved cysteines
Other important regulators of programmed cell deathand histidine in the signature sequence chelates a zinc.
are the Bcl-2 family of proteins. Members of this family,To determine which amino acids of XIAP are responsible
such as Bcl-2 and Bcl-xL, can inhibit apoptosis, whereasfor its antiapoptotic activity, site-directed mutants of
others promote cell death (e.g., Bax, Bak, Bad, and Bid).XIAP were prepared and tested for their ability to inhibit
The antiapoptotic proteins interact with the proapo-caspase-3. Surprisingly, the residues found to be most
ptotic family members to form heterodimers that modu-important for caspase-3 inhibition are not in the BIR
late each other’s activity. In fact, the relative levels ofdomain but in the linker region between the BIR1 and
these proteins in a cell determine whether a cell will liveBIR2 domains. Based on NMR studies on the interaction
or die (Yin et al., 1994).of XIAP with caspase-3, it was postulated that this linker
Many of the Bcl-2 proteins contain a hydrophobicregion binds to the active site and the BIR2 domain
C-terminal tail that is responsible for localizing the pro-interacts with an adjacent site on the enzyme (Sun et al.,
teins to the mitochondrial outer membrane, endoplas-1999). This is consistent with the amino acid sequence
mic reticulum, and nuclear membrane. The antiapo-(DISD) within the linker region that resembles the se-
ptotic family members also contain Bcl-2 homology (BH)quence found in substrates and inhibitors of caspase-3.
regions that are important for their antiapoptotic activityThe NMR structures of the BIR3 domain of XIAP (Sun
(BH1, BH2, BH3, and BH4). Some of the proapoptoticet al., 2000) and cIAP-1 (MIHB) (Hinds et al., 1999) have
Bcl-2 proteins also contain BH1, BH2, and BH3 regionsalso been determined. The structure of the BIR3 domain
while others only contain a BH3 region (Kelekar andof XIAP is very similar to the BIR2 domain of XIAP (Sun
Thompson, 1998). The BH3 region is responsible foret al., 2000). However, the structure of the BIR3 domain
both binding to the antiapoptotic proteins and the abilityof c-IAP-1 is different than the structure of the BIR2 and
to promote programmed cell death (Chittenden et al.,BIR3 domain of XIAP, which is surprising in light of
1995). Interestingly, the proapoptotic family membersthe high sequence homology among the IAP family of
that contain BH1 and BH2 regions such as Bax canproteins (Uren et al., 1998). The major difference in the
promote cell death independent from their ability to in-BIR3 domain of c-IAP-1 is the lack of the b sheet found
teract with antiapoptotic proteins through interactionsin the BIR2 and BIR3 domain of XIAP and classical zinc
with mitochondrial membranes.fingers.
The three-dimensional structure of Bcl-xL was deter-X-ray structures of the IAP, survivin, have also been
mined by both X-ray crystallography and NMR spectros-recently reported (Chantalat et al., 2000; Muchmore et
copy (Muchmore et al., 1996). The structure consists ofal., 2000; Verdecia et al., 2000). The structure consists
two central, predominantly hydrophobic a helices thatof an N-terminal BIR domain that resembles the struc-
are flanked on both sides by amphipathic a helices (Fig-tures of the BIR2 and BIR3 domains of XIAP and a long,
ure 9A). A large, flexible loop of about 50 amino acidsC-terminal a helix. Unlike the BIR domains of XIAP and
is located between a1 and a2. To determine whetherc-IAP-1, which are monomers, both human and mouse
this loop was functionally important, it was removed.survivin exist as dimers (although the dimeric arrange-
Instead of inhibiting the antiapoptotic activity of Bcl-ment differs in the different crystal structures). Since
xL and Bcl-2, loop-deleted mutants of these proteinssurvivin is expressed in many cancers but not in normal
adult tissues (Ambrosini et al., 1997), survivin represents enhanced their ability to inhibit programmed cell death,
Review
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Figure 10. Blow-Up of the Bcl-xL/Bak Peptide Complex
The Bak peptide (green) adopts an amphipathic a helix and binds
into a hydrophobic cleft (yellow) in Bcl-xL. The complex is stabilized
by hydrophobic interactions involving Leu78 and Ile81 of Bak and
electrostatic interactions between R76 and D83 of Bak and E129
and R139 of Bcl-xL. (Sattler, et al., 1997). Figure 11. NMR Structure of BID (Chou et al., 1999)
of Bcl-xL complexed to the death-promoting BH3 regionsuggesting that the loop region plays a negative regula-
tory role in the signaling of programmed cell death of the Bak protein indicated that the Bak peptide adopts
an amphipathic a helix that interacts with Bcl-xL through(Chang et al., 1997).
Another interesting feature of the Bcl-xL structure is specific hydrophobic and electrostatic interactions (Fig-
ure 10) (Sattler et al., 1997). The relative importance ofits similarity to the pore-forming domains of bacterial
toxins (Muchmore et al., 1996). Both Bcl-xL and bacterial these interactions revealed from the structure of the
complex and binding measurements of Bak mutant pep-toxins such as diphtheria toxin and the colicins contain
two central, hydrophobic a helices of about 30 A˚ in tides define the binding affinity and specificity observed
within the Bcl-2 family of proteins.length that are surrounded by amphipathic a helices
(Figure 9). Based on this structural similarity, it was pos- The NMR structure of a proapoptotic member of the
Bcl-2 family, BID, has also been recently determinedtulated that Bcl-2 proteins may form pores in mem-
branes (Muchmore et al., 1996) analogous to the struc- (Chou et al., 1999; McDonnell et al., 1999). Despite the
lack of sequence homology, the structure of BID (Figureturally similar bacterial toxins (London, 1992). Indeed,
Bcl-xL (Minn et al., 1997) as well as other members of 11) is very similar to that of Bcl-xL (Figure 9A). The only
differences are in the length and orientations of somethe Bcl-2 family (Antonsson et al., 1997; Schendel et al.,
1997; Schlesinger et al., 1997) were shown to insert into of the helices and the extra a helix (Figure 11, magenta)
found in BID. On the basis of the structure, a mechanismsynthetic lipid vesicles or planar lipid bilayers and form
pH-dependent, ion-conducting channels. Although it is was postulated for the increase in BID’s proapoptotic
activity upon cleavage in the loop region by caspase-8still unclear if these channels are functionally involved
in apoptosis, pore formation by Bcl-2 proteins has been (Figure 11) (Li et al., 1998b; Luo et al., 1998). This pro-
posed mechanism involves the exposure of the BH3hypothesized to be important for regulating the release
of cytochrome c and perturbing mitochondrial physiol- region, which enhances the binding of BID to Bcl-xL,
and the exposure of a hydrophobic surface, leading toogy (Vander Heiden et al., 1997). The structure of the
membrane-associated form of Bcl-2 proteins could be the translocation of truncated BID to the mitochondrial
membrane. Consistent with the structural analysis, thevery useful for understanding their mode of action. How-
ever, the structures of membrane-associated proteins ion channel activity of BID in model membranes was
found to be dependent on the caspase-mediated cleav-are difficult to obtain. As a first step, the structure of Bcl-
xL in detergent micelles was characterized (Losonczi age of the protein (Schendel et al., 1999).
et al., 2000). The structure of Bcl-xL in membrane-like
environment was very different from its structure in Conclusions and Future Perspectives
Three-dimensional structures of many proteins that reg-aqueous solution. In the micelle, Bcl-xL has a loosely
packed dynamic structure with helices 1, 6, and 5 par- ulate or directly participate in the major signaling path-
ways of programmed cell death have been determined.tially buried in the hydrophobic interior and the other
portions of the protein near or on the outside of the These structures have taught us how ligands such as
TNF-b and TRAIL recognize death receptors and howmicelle.
The functionally important BH1, BH2, and BH3 regions small protein modules (death domains, death effector
domains, caspase recruitment domains, and the N-ter-of Bcl-xL are distant in the primary sequence; however,
they are located in the same portion of the tertiary struc- minal domain of CIDE proteins) participate in homophilic
interactions important in cell death signaling. From theture and form a hydrophobic cleft that interacts with
proapoptotic Bcl-2 family members. The NMR structure structures of caspase/inhibitor complexes, we’ve learned
Cell
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Biochemical pathways of caspase activation during apoptosis.about their mechanism for protease cleavage and the
Annu. Rev. Cell Dev. Biol. 15, 269–290.structural basis for substrate and inhibitor recognition.
Carson, M.J. (1987). Ribbon models of macromolecules. J. Mol.This information will be important for designing selective
Graph. 5, 103–106.inhibitors of this family of enzymes that have potential
Chang, B.S., Minn, A.J., Muchmore, S.W., Fesik, S.W., and Thomp-clinical utility for the treatment of stroke and acute myo-
son, C.B. (1997). Identification of a novel regulatory domain in Bcl-cardial infarction. Structural and mutagenesis studies
xL and Bcl-2. EMBO J. 16, 968–977.of the IAPs have defined the important residues for the
Chantalat, L., Skoufias, D.A., Kleman, J.-P., Jung, B., Dideberg, O.,interaction of XIAP with caspase-3 and suggest how
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